Vivimed arm Klar Sehen divests certain products to Ordain Healthcare for Rs 73 cr

The move is part of Vivimed's strategy to exit from the branded formulations in ophthalmology and to focus on CMO and US generic business

Klar Sehen's ophthalmology drug
Klar Sehen's ophthalmology drug
Rakesh Rao Mumbai
Last Updated : Aug 04 2016 | 11:37 AM IST

Don't want to miss the best from Business Standard?

Klar Sehen Pvt Ltd, a wholly owned subsidiary of the Hyderabad-based integrated pharmaceuticals company Vivimed Labs Ltd, has sold certain products along with their associated trademarks to Ordain Healthcare Global Pvt Ltd, a subsidiary of Spain-based Chemo Espana S A. The total consideration for the identified product lines is Rs 73 crore.

Further, as part of the transaction, Klar Sehen will provide contract manufacturing services for the divested products to Ordain Healthcare for an agreed period of time from its two plants located at Hyderabad and Kolkata.

ALSO READ: Clariant to acquire a part of Vivimed Labs' personal care portfolio

Santosh Varalwar, managing director, Vivimed Labs, said, “This is a very important strategic development at Vivimed. As part of our strategy, the company has exited from the branded formulations in ophthalmology and will continue to focus on CMO and US generic business. Furthermore, this transaction will also provide us enhanced financial flexibility by further reducing debt as we transition into the next phase of growth.”

Klar Sehen, two German words meaning ‘clear vision’, focusses on ophthalmology as its core competence, with also presence in other therapeutic segments such as ENT, paediatrics, gynaecology and broad-based general medicine.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 26 2016 | 4:29 PM IST

Next Story